Evidence map›Paper›PMID 40682180›Full record

ArticleGenome biology2025

Epigenetic priming of mammalian embryonic enhancer elements coordinates developmental gene networks.

Christopher D Todd, Jannat Ijaz, Fereshteh Torabi, Oleksandr Dovgusha, Stephen Bevan, Olivia Cracknell, Tim Lohoff, Stephen Clark, Ricard Argelaguet, Juliette Pearce and 7 more

Erratum issuedAbstract read
In one paragraph

Article in Genome biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors.

Christopher D ToddEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK. ctodd@altoslabs.com.
Jannat IjazEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Fereshteh TorabiEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Oleksandr DovgushaGöttingen Center for Molecular Biology, Department of Developmental Biology, University of Göttingen, Justus-Von-Liebig Weg 11, Göttingen, 37077, Germany.
Stephen BevanEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Olivia CracknellEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Tim LohoffEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Stephen ClarkEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Ricard ArgelaguetEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Juliette PearceEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Ioannis KafetzopoulosEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Alice SantambrogioEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Jennifer NicholsWellcome-MRC Cambridge Stem Cell Institute, Jeffrey Cheah Biomedical Centre, University of Cambridge, Puddicombe Way, Cambridge, CB2 0AW, UK.
Ferdinand von MeyennEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK.
Ufuk GünesdoganGöttingen Center for Molecular Biology, Department of Developmental Biology, University of Göttingen, Justus-Von-Liebig Weg 11, Göttingen, 37077, Germany.
Stefan SchoenfelderEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK. stefan.schoenfelder@babraham.ac.uk.
Wolf ReikEpigenetics Programme, Babraham Institute, Babraham Research Campus, Cambridge, CB22 3AT, UK. wreik@altoslabs.com.

Funding

BBSRC Flexible Talent and Mobility Account FTMABBSRC Industrial CASE training grant BB/W510087/1Biotechnology and Biological Sciences Research Council BBS/E/B/000C0421European Research Council EpiCell Linage:882798Humboldt Foundation Sofja Kovalevskaja AwardUK Research and Innovation MR/T016787/1Wellcome Collaborative award 220379/Z/20/ZWellcome Investigator Award 210754/B/18/ZWellcome TrustWellcome Trust 210754/Z/18/Z
6 · The paper itself

Abstract

backgroundEmbryonic development requires the accurate spatiotemporal execution of cell lineage-specific gene expression programs, which are controlled by transcriptional enhancers. Developmental enhancers adopt a primed chromatin state prior to their activation. How this primed enhancer state is established and maintained and how it affects the regulation of developmental gene networks remains poorly understood.

resultsHere, we use comparative multi-omic analyses of human and mouse early embryonic development to identify subsets of postgastrulation lineage-specific enhancers which are epigenetically primed ahead of their activation, marked by the histone modification H3K4me1 within the epiblast. We show that epigenetic priming occurs at lineage-specific enhancers for all three germ layers and that epigenetic priming of enhancers confers lineage-specific regulation of key developmental gene networks. Surprisingly in some cases, lineage-specific enhancers are epigenetically marked already in the zygote, weeks before their activation during lineage specification. Moreover, we outline a generalizable strategy to use naturally occurring human genetic variation to delineate important sequence determinants of primed enhancer function.

conclusionsOur findings identify an evolutionarily conserved program of enhancer priming and begin to dissect the temporal dynamics and mechanisms of its establishment and maintenance during early mammalian development.

Indexed as

Embryonic DevelopmentEnhancer Elements, GeneticEpigenesis, GeneticGene Expression Regulation, DevelopmentalGene Regulatory NetworksAnimalsCell LineageHistonesHumansMiceHistonesCell fateDevelopmental biologyEmbryogenesisEnhancersEpigeneticsMulti-omics

Identifiers

PMID40682180
PMCPMC12272991

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.